Surgical Science Sweden AB (SUS) — Cash Flow-to-Debt Ratio
Surgical Science Sweden AB (SUS) has a Cash Flow-to-Debt Ratio of 0.17x as of December 2025, meaning its operating cash flow of Skr72.89 Million could theoretically repay 0% of its total liabilities (Skr418.31 Million) in one year. Check Surgical Science Sweden AB (SUS) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Surgical Science Sweden AB Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Surgical Science Sweden AB across 11 annual periods. Also explore total assets of Surgical Science Sweden AB for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Surgical Science Sweden AB (2015–2025)
Year-by-year debt coverage analysis for Surgical Science Sweden AB. For market capitalisation and broader financial context, see Surgical Science Sweden AB (SUS) total market value.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | Skr79.80 Million | Skr418.31 Million | ▼ -9.5% |
| 2024 | 0.21x | Skr137.22 Million | Skr651.03 Million | ▼ -68.4% |
| 2023 | 0.67x | Skr238.29 Million | Skr357.46 Million | ▲ +112.7% |
| 2022 | 0.31x | Skr129.49 Million | Skr413.11 Million | ▲ +215.2% |
| 2021 | 0.10x | Skr39.08 Million | Skr393.06 Million | ▼ -80.6% |
| 2020 | 0.51x | Skr23.23 Million | Skr45.22 Million | ▼ -49.3% |
| 2019 | 1.01x | Skr55.20 Million | Skr54.54 Million | ▲ +198.4% |
| 2018 | 0.34x | Skr6.88 Million | Skr20.28 Million | ▼ -42.7% |
| 2017 | 0.59x | Skr7.94 Million | Skr13.40 Million | ▲ +82.6% |
| 2016 | 0.32x | Skr13.40 Million | Skr41.30 Million | ▲ +51.8% |
| 2015 | 0.21x | Skr7.50 Million | Skr35.10 Million | — |